Edition:
Deutschland

Abiomed Inc (ABMD.OQ)

ABMD.OQ on NASDAQ Stock Exchange Global Select Market

262.76USD
19:21 Uhr
Change (% chg)

$-2.92 (-1.10%)
Prev Close
$265.68
Open
$265.45
Day's High
$265.45
Day's Low
$261.75
Volume
22,866
Avg. Vol
228,467
52-wk High
$285.65
52-wk Low
$119.46

About

ABIOMED, Inc. is a provider of temporary percutaneous mechanical circulatory support devices. The Company offers care to heart failure patients. The Company operates in the segment of the research, development and sale of medical devices to assist or replace the pumping function of the failing heart. The Company develops,... (more)

Buy/Sell

Sell Hold Buy
2.33 Mean rating from 9 analysts

Overall

Beta: 0.92
Market Cap(Mil.): $11,967.33
Shares Outstanding(Mil.): 45.04
Dividend: --
Yield (%): --

BRIEF-Abiomed Appoints Charles Simonton As New Chief Medical Officer

* ABIOMED APPOINTS NEW CHIEF MEDICAL OFFICER CHARLES SIMONTON, M.D. Source text for Eikon: Further company coverage:

BRIEF-FDA Approves Abiomed’s First-In-Human Trial Of Impella ECP

* FDA APPROVES ABIOMED’S FIRST-IN-HUMAN TRIAL OF IMPELLA ECP, WORLD’S SMALLEST HEART PUMP Source text for Eikon: Further company coverage:

FDA approves emergency use of Abiomed heart pump for COVID-19 patients

June 1 Abiomed Inc said on Monday the U.S. Food and Drug Administration has granted emergency use authorization for its temporary invasive heart pump to help patients suffering from COVID-19 related right heart failure.

BRIEF-FDA Issues EUA For Impella RP For Covid-19 Patients With Right Heart Failure

* FDA ISSUES EMERGENCY USE AUTHORIZATION FOR IMPELLA RP AS THERAPY FOR COVID-19 PATIENTS WITH RIGHT HEART FAILURE Source text for Eikon: Further company coverage:

U.S. RESEARCH ROUNDUP- Comcast, Mirati Therapeutics, Oceanfirst Financial

May 1 Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Comcast, Mirati Therapeutics and Oceanfirst Financial, on Friday. HIGHLIGHTS * Comcast Corp : Keybanc cuts to sector weight from overweight * Mirati Therapeutics Inc : JP Morgan raises to overweight from neutral * Oceanfirst Financial Corp : Stephens raises to overweight from equal-weight * Wolveri

BRIEF-Abiomed Announces Q4 FY 2020 Revenue Of $207 Million And 28.1% Operating Margin

* ABIOMED ANNOUNCES Q4 FY 2020 REVENUE OF $207 MILLION AND 28.1% OPERATING MARGIN

BRIEF-Abiomed’S Response To The Covid-19 Pandemic

* ABIOMED INC - IN FY21, ABIOMED WILL TRANSITION MAJORITY OF CO'S PATIENTS AND HOSPITALS TO IMPELLA CONNECT PLATFORM

BRIEF-Study Of 21,848 High-Risk PCI Patients Demonstrates Lower Risk Of Death And Complications In Patients Who Receive PVADs (Impella)

* STUDY OF 21,848 HIGH-RISK PCI PATIENTS DEMONSTRATES LOWER RISK OF DEATH AND COMPLICATIONS IN PATIENTS WHO RECEIVE PVADS (IMPELLA) Source text for Eikon: Further company coverage:

Märkte

  • U.S.
  • Europa
  • Asien
  • Branchen

Branchenüberblick

Energie +0.74%
Rohstoffe +0.28%
Industrie +0.59%
Konjunktur abhängige Waren & Dienstleistungen +0.92%
Konjunktur unabhängige Waren & Dienstleistungen +1.38%
Finanzindustrie -0.52%
Pharma -0.14%
Technologie +0.59%
Telekommunikation +1.41%